Socioeconomic factors, attitudes and practices associated with malaria prevention in the coastal plain of Chiapas, Mexico

Por Mora-Ruiz, Merit, Penilla, R Patricia, Ordóñez, José G, López, Alma D, Solis, Francisco, Torres-Estrada, José Luis, Rodríguez, Américo D
Publicado em 2014

IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis

Por Martins, Ana Sofia, Ordóñez, José Luis, Amaral, Ana Teresa, Prins, Frans, Floris, Giuseppe, Debiec-Rychter, Maria, Hogendoorn, Pancras C. W., de Alava, Enrique
Publicado em 2011

Molecular Certification Laboratory of Arauco

Por Núñez, Paulina, Balocchi, Claudio, De Veer, Christian, Muñoz, Ximena, Bustos, Emilio, Bilabel, Philipp, Ramirez, Mauricio, Millar, Marcela, Lavados, Patricio, Ordoñez, Jose, Villalobos, Liliana
Publicado em 2011

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia

Por García-Tuñón, Ignacio, Hernández-Sánchez, María, Ordoñez, José Luis, Alonso-Pérez, Veronica, Álamo-Quijada, Miguel, Benito, Rocio, Guerrero, Carmen, Hernández-Rivas, Jesús María, Sánchez-Martín, Manuel
Publicado no Oncotarget (2017)

Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications

Por Amaral, Ana Teresa, Manara, Maria Cristina, Berghuis, Dagmar, Ordóñez, José Luis, Biscuola, Michele, Lopez-García, Maria Angeles, Osuna, Daniel, Lucarelli, Enrico, Alviano, Francesco, Lankester, Arjan, Scotlandi, Katia, de Álava, Enrique
Publicado em 2014

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Por Ordóñez, José Luis, Amaral, Ana Teresa, Carcaboso, Angel M., Herrero-Martín, David, García-Macías, María del Carmen, Sevillano, Vicky, Alonso, Diego, Pascual-Pasto, Guillem, San-Segundo, Laura, Vila-Ubach, Monica, Rodrigues, Telmo, Fraile, Susana, Teodosio, Cristina, Mayo-Iscar, Agustín, Aracil, Miguel, Galmarini, Carlos María, Tirado, Oscar M., Mora, Jaume, de Álava, Enrique
Publicado no Oncotarget (2015)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Por Ordóñez, José Luis, Amaral, Ana Teresa, Carcaboso, Angel M., Herrero-Martín, David, García-Macías, María del Carmen, Sevillano, Vicky, Alonso, Diego, Pascual-Pasto, Guillem, San-Segundo, Laura, Vila-Ubach, Monica, Rodrigues, Telmo, Fraile, Susana, Teodosio, Cristina, Mayo-Iscar, Agustín, Aracil, Miguel, Galmarini, Carlos María, Tirado, Oscar M., Mora, Jaume, de Álava, Enrique
Publicado no Oncotarget (2017)